Spironolactone: diuretic or disease-modifying drug in heart failure with preserved ejection fraction?

Frederik H Verbrugge*, Kevin Damman

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

2 Citations (Scopus)
83 Downloads (Pure)
Original languageEnglish
Pages (from-to)1611-1614
Number of pages4
JournalEuropean Journal of Heart Failure
Volume22
Issue number9
DOIs
Publication statusPublished - Sept-2020

Cite this